Wesleyan Assurance Society reduced its stake in shares of Corteva, Inc. (NYSE:CTVA – Free Report) by 24.6% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 23,000 shares of the company’s stock after selling 7,521 shares during the quarter. Wesleyan Assurance Society’s holdings in Corteva were worth $1,555,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently modified their holdings of CTVA. Empirical Finance LLC increased its holdings in shares of Corteva by 0.6% in the second quarter. Empirical Finance LLC now owns 24,935 shares of the company’s stock worth $1,858,000 after acquiring an additional 153 shares in the last quarter. Fox Run Management L.L.C. lifted its holdings in shares of Corteva by 5.1% during the 3rd quarter. Fox Run Management L.L.C. now owns 3,361 shares of the company’s stock valued at $227,000 after purchasing an additional 164 shares in the last quarter. IFG Advisory LLC grew its position in shares of Corteva by 1.7% in the 3rd quarter. IFG Advisory LLC now owns 9,764 shares of the company’s stock valued at $660,000 after purchasing an additional 166 shares during the period. United Community Bank grew its position in shares of Corteva by 10.5% in the 3rd quarter. United Community Bank now owns 1,849 shares of the company’s stock valued at $125,000 after purchasing an additional 176 shares during the period. Finally, Binnacle Investments Inc increased its stake in Corteva by 54.7% during the 2nd quarter. Binnacle Investments Inc now owns 512 shares of the company’s stock worth $38,000 after purchasing an additional 181 shares in the last quarter. 81.54% of the stock is owned by institutional investors.
Analysts Set New Price Targets
A number of brokerages recently commented on CTVA. CICC Research raised their price objective on shares of Corteva from $70.00 to $80.00 and gave the stock an “outperform” rating in a report on Wednesday, February 11th. Wolfe Research upped their target price on shares of Corteva from $81.00 to $86.00 and gave the stock an “outperform” rating in a research note on Thursday, February 5th. Citigroup increased their target price on Corteva from $74.00 to $80.00 and gave the stock a “neutral” rating in a report on Thursday, February 5th. Oppenheimer set a $86.00 price target on Corteva in a research note on Thursday, February 5th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Corteva in a report on Monday, December 29th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Corteva currently has a consensus rating of “Moderate Buy” and a consensus price target of $82.90.
Corteva Stock Performance
Shares of NYSE CTVA opened at $78.36 on Tuesday. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.43 and a quick ratio of 0.96. The stock’s fifty day moving average price is $73.22 and its two-hundred day moving average price is $69.04. Corteva, Inc. has a one year low of $53.40 and a one year high of $80.90. The firm has a market cap of $52.70 billion, a price-to-earnings ratio of 49.59, a P/E/G ratio of 2.63 and a beta of 0.72.
Corteva (NYSE:CTVA – Get Free Report) last announced its earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.22. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The company had revenue of $3.91 billion during the quarter, compared to analysts’ expectations of $4.23 billion. During the same quarter in the previous year, the business posted $0.32 earnings per share. Corteva’s quarterly revenue was down 1.7% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, equities analysts forecast that Corteva, Inc. will post 2.96 EPS for the current year.
Corteva Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 16th. Investors of record on Monday, March 2nd will be paid a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Monday, March 2nd. Corteva’s dividend payout ratio (DPR) is 45.57%.
Insider Activity
In other news, insider Brian Titus sold 8,311 shares of the business’s stock in a transaction on Friday, February 20th. The stock was sold at an average price of $76.55, for a total transaction of $636,207.05. Following the completion of the transaction, the insider owned 8,090 shares of the company’s stock, valued at approximately $619,289.50. The trade was a 50.67% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.15% of the company’s stock.
Corteva Company Profile
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Read More
- Five stocks we like better than Corteva
- Buy this Gold Stock Before May 15th, 2026
- Read this or regret it forever
- J.P. Morgan is betting on this coin
- Central banks just did something they haven’t done since 1967
- My Epstein Story
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
